Table 4.
Associations Between Regional Adipose Tissue, Adipocytokines and Neuropsychiatric Test Scores After Controlling for HIV-Specific Factors
Controlled for demographics* and HIV-specific factors**: | VAT | aSAT | tSAT | adiponectin | leptin | IL-6 | hs-CRP |
---|---|---|---|---|---|---|---|
TA | 0.98 (0.55) | 0.98 (0.67) | 0.98 (0.73) | 1.10 (0.13) | 1.02 (0.37) | 1.07 (0.09) | 1.02 (0.65) |
TB | 1.00 (0.94) | 1.10 (0.13) | 1.07 (0.19) | 1.10 (0.20) | 1.07 (0.11) | 1.07 (0.17) | 1.00 (0.82) |
SymD | 1.74 (0.37) | −0.54 (0.77) | −1.91 (0.18) | −5.59 (<0.01) | −2.00 (0.18) | −3.33 (0.07) | −1.81 (0.19) |
Note 1: For TA and TB, beta estimates <1 indicate better performance. For SymD, beta estimates >1 indicate better performance.
Note 2: No interaction was observed between adipose tissue depots.
Includes age, race, and education
HIV-specific factors=Current antiretroviral therapy (ART), current CD4 T cell count and nadir CD4 T cell count. Inclusion of years on ART, HIV-1 viral load, and/or history of AIDS diagnosis did not improve model fit. When CD4 count stratified by <200, <500, or >500 cells/μL, significant effect of CD4<500 cells/μL found for Trails A only. CD4-by-age interaction existed for current CD4<200 cells/μL.
TA=Trails A, TB=Trails B, SymD=symbol-digit, VAT=visceral adipose tissue, aSAT=abdominal subcutaneous adipose tissue, tSAT=thigh subcutaneous adipose tissue, IL-6=interleukin-6, hs-CRP=high-sensitivity C-reactive protein